12:03 PM EST - Ondine Biopharma Corp. : reported fourth-quarter loss of $2.12 million or $0.03 per share, compared to loss of $2.73 million or $0.05 per share last year. Product sales grew to $302,000 from $128,000 in the comparable period a year ago. Ondine Biopharma Corp.
shares T.OBP are trading even at $0.08.
